Incanthera plc (AQU: INC)

Market Cap	26.89M
Revenue (ttm)	n/a
Net Income (ttm)	-1.55M
Shares Out	116.90M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 20, 2024

About Incanthera

Incanthera plc, a dermatology and oncology therapeutics company, focuses on the dermatological formulation and delivery technologies for various indications. The company’s lead product Sol is a topical product for the treatment of solar keratosis and the prevention of skin cancers. It is also involved in the development of EP0015 for the treatment of lung, breast, ovarian, and prostate cancers, currently under lead and pre-clinical stage; Equin for the treatment of liver, brain, and pancreatic cancers, currently under pre-clinical stage; and Du...

• Industry: Pharmaceutical Preparations
• Founded: 2010
• Employees: 7
• Stock Exchange: Aquis Exchange
• Ticker Symbol: INC